CEO
Bennu Biotherapeutics
The startup develops T cell therapy technologies that target tumor and autoimmune diseases through a proprietary T cell fate regulation platform and T cell engineering transformation platform. This approach enhances the precision and efficacy of treatments in oncology and autoimmune care, addressing the need for more effective therapeutic options in these challenging medical areas.
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops T cell therapy technologies that target tumor and autoimmune diseases through a proprietary T cell fate regulation platform and T cell engineering transformation platform. This approach enhances the precision and efficacy of treatments in oncology and autoimmune care, addressing the need for more effective therapeutic options in these challenging medical areas.